CD

Cadre Holdings, Inc.

CDREIndustrialsNASDAQ

Aerospace & Defense

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$610.3M
+7.5% YoY
Net Income
$44.1M
+22.2% YoY
EBITDA
$93.4M
+19.1% YoY
Free Cash Flow
$23.7M

Scan Results

Daily timeframe
DateIndicatorDetails
Jul 8 MACD Positive CrossoverHistogram +0.2067, positive momentum
Jul 7 MACD Positive CrossoverHistogram +0.2008, positive momentum
About Cadre Holdings, Inc.

Part of the industrials sector, Cadre Holdings, Inc. (CDRE) is listed under Aerospace & Defense. With a market capitalization of $1.24B, it sits in small-cap territory. It operates through two segments, Product and Distribution.

Key stats
Market Cap$1.24B
P/E (TTM)35.88
Fwd P/E20.32
EPS$0.81
Beta1.32
52W Change-11.0%
Dividend Yield1.29%
ROE11.3%
Analysis

The company holds $42.2M in cash, though total debt stands at $389.7M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $23.7M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 11.3%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 6.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $457.8M (2022) to $610.3M (2025), reflecting a 33% increase over the period.

The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Cadre Holdings, Inc. and its sector.

Links
More Industrials stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms